Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans

Health Education and Behavior

Volumn 36, Issue 1, 2009, Pages 127-137

  Schoenthaler, Antoinette ^a   Ogedegbe, Gbenga ^b   Allegrante, John P ^a  

^a Howard Hughes Medical Institute   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

African American; Depressive symptoms; Hypertension; Medication adherence; Self efficacy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AFRICAN AMERICAN; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REVIEW; SELF CONCEPT;

AFRICAN AMERICANS; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SELF EFFICACY;

EID: 59049096893     PISSN: 10901981     EISSN: 15526127     Source Type: Journal    
DOI: 10.1177/1090198107309459     Document Type: Review

References (37)

1. Allegrante, J. P., & Marks, R. (2003). Self-efficacy in management of osteoarthritis. Rheumatic-Disease Clinics of North America, 29(4), 747-768.
2. Arnstein, P. (2000). The mediation of disability by self efficacy in different samples of chronic pain patients. Disability and Rehabilitation, 22(11), 794-801.
3. Aroian, L. A. (1947). The probability function of the product of two normally distributed variables. Annals of Mathematical Statistics, 18, 265-270.
4. Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84(2), 191-215.
5. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173-1182.
6. Beck, A. T. (1967). Depression: Clinical, experimental, and theoretical aspects. New York: Hoeber Medical Division.
7. Bertakis, K. D., Helms, L. J., Callahan, E. J., Azari, R., Leigh, P., & Robbins, J. A. (2001). Patient gender differences in the diagnosis of depression in primary care. Journal of Women's Health and Gender Based Medicine, 10(7), 689-698.
8. Bosworth, H. B., Dudley, T., Olsen, M. K., Voils, C. I., Powers, B., Goldstein, M. K., et al. (2006). Racial differences in blood pressure control: Potential explanatory factors. American Journal of Medicine, 119(1), e79-e115.
9. Brus, H., van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (1999). Determinants of compliance with medication in patients with rheumatoid arthritis: The importance of self-efficacy expectations. Patient Education and Counseling, 36(1), 57-64.
10. Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40(5), 373-383.
11. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jr., et al. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. Journal of the American Medical Association, 289(19), 2560-2572.
12. Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000). Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Archives of Internal Medicine, 160(21), 3278-3285.
13. Cinciripini, P. M., Wetter, D. W., Fouladi, R. T., Blalock, J. A., Carter, B. L., Cinciripini, L. G., et al. (2003). The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. Journal of Consulting and Clinical Psychology, 71(2), 292-301.
14. Clark, N. M., & Dodge, J. A. (1999). Exploring self-efficacy as a predictor of disease management. Health Education and Behavior, 26(1), 72-89.
15. Farmer, M. E., Locke, B. Z., Moscicki, E. K., Dannenberg, A. L., Larson, D. B., & Radloff, L. S. (1988). Physical activity and depressive symptoms: The NHANES I Epidemiologic Followup Study. American Journal of Epidemiology, 128(6), 1340-1351.
16. Hertz, R. P., Unger, A. N., Cornell, J. A., & Saunders, E. (2005). Racial disparities in hypertension prevalence, awareness, and management. Archives of Internal Medicine, 165(18), 2098-2104.
17. Katz, R. C., Ashmore, J., Barboa, E., Trueblood, K., McLaughlin, V., & Mathews, L. (1998). Knowledge of disease and dietary compliance in patients with end-stage renal disease. Psychological Reports, 82(1), 331-336.
18. Kim, M. T., Han, H. R., Hill, M. N., Rose, L., & Roary, M. (2003). Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive Black men. Annals of Behavioral Medicine, 26(1), 24-31.
19. Kobau, R., & Dilorio, C. (2003). Epilepsy self-management: A comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviors among people with epilepsy. Epilepsy Behavior, 4(3), 217-225.
20. MacKinnon, D. P., Warsi, G., & Dwyer, J. H. (1995a). A simulation study of mediated effect measures. Multivariate Behavioral Research, 30(1), 41-62.
21. MacKinnon, D. P., Waris, G., & Dwyer, J. H. (1995b). "A simulation study of mediated effect measures": Erratum. Multivariate Behavioral Research, 30(3), ii.
22. Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67-74.
23. Neutel, J. M., & Smith, D. H. (2003). Improving patient compliance: A major goal in the management of hypertension. Journal of Clinical Hypertension (Greenwich), 5(2), 127-132.
24. Ogedegbe, G., Mancuso, C. A., Allegrante, J. P., & Charlson, M. E. (2003). Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. Journal of Clinical Epidemiology, 56(6), 520-529.
25. Ogedegbe, G., Schoenthaler, A., Richardson, T., Lewis, L., Belue, R., Espinosa, E., et al. (2007). An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: Rationale and design. Contemporary Clinical Trials, 28(2), 169-181.
26. O'Leary, A. (1985). Self-efficacy and health. Behavioral Research and Therapy, 23(4), 437-451.
27. Ong, K. L., Cheung, B. M., Man, Y. B., Lau, C. P., & Lam, K. S. (2007). Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension, 49(1), 69-75.
28. Rose, L. E., Kim, M. T., Dennison, C. R., & Hill, M. N. (2000). The contexts of adherence for African Americans with high blood pressure. Journal of Advanced Nursing, 32(3), 587-594.
29. Sacco, W. P., Wells, K. J., Vaughan, C. A., Friedman, A., Perez, S., & Matthew, R. (2005). Depression in adults with Type 2 diabetes: The role of adherence, body mass index, and selfefficacy. Health Psychology, 24(6), 630-634.
30. Shea, S., Misra, D., Ehrlich, M. H., Field, L., & Francis, C. K. (1992). Correlates of nonadherent to hypertension treatment in an inner-city minority population. American Journal of Public Health, 82(12), 1607-1612.
31. Sobel, M. (1982). Asymptotic intervals for indirect effects in structural equations models. In S. Leinhart (Ed.), Sociological methodology (pp. 290-312). San Francisco: Jossey-Bass.
32. Sowers, J. R., Ferdinand, K. C., Bakris, G. L., & Douglas, J. G. (2002). Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome. Postgraduate Medicine, 112(4), 24-26, 29-30, 33-34.
33. Wang, P. S., Avorn, J., Brookhart, M. A., Mogun, H., Schneeweiss, S., Fischer, M. A., et al. (2005). Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension, 46(2), 273-279.
34. Wang, P. S., Bohn, R. L., Knight, E., Glynn, R. J., Mogun, H., & Avorn, J. (2002). Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. Journal of General Internal Medicine, 17(7), 504-511.
35. Wing, R. R., Phelan, S., & Tate, D. (2002). The role of adherence in mediating the relationship between depression and health outcomes. Journal of Psychosomatic Research, 53(4), 877-881.
36. Wong, M. D., Shapiro, M. F., Boscardin, W. J., & Ettner, S. L. (2002). Contribution of major diseases to disparities in mortality. New England Journal of Medicine, 347(20), 1585-1592.
37. World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization.